VITASPRING BIOMEDICAL CO., LTD. (VSBC) Net income 2017–2026
VITASPRING BIOMEDICAL CO., LTD. (VSBC) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$415,368FY2026 · since FY2017: -$45 → -$415,368
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$415,368 | +46.4% |
| FY2025 | -$774,922 | +30.7% |
| FY2024 | -$1.1M | +73.1% |
| FY2023 | -$4.2M | -557.8% |
| FY2022 | $909,560 | +113.8% |
| FY2021 | $425,382 | +6048.0% |
| FY2020 | $6,919 | +130.9% |
| FY2019 | -$22,396 | -251.4% |
| FY2018 | -$6,374 | -14064.4% |
| FY2017 | -$45 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net marginVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating marginVSBC Operating cash flowVSBC Free cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →